|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 2301 to 2400 out of 2570 for Kras

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.045s

Categories

Category: Publication
« show all
Type Details Score
Publication
23056544 | J:192099
First Author: Helmy K
Year: 2012
Journal: PLoS One
Title: Identification of global alteration of translational regulation in glioma in vivo.
Volume: 7
Issue: 10
Pages: e46965
•
•
•
•
•
Publication
21267448 | J:208757
First Author: Pitter KL
Year: 2011
Journal: PLoS One
Title: Perifosine and CCI 779 co-operate to induce cell death and decrease proliferation in PTEN-intact and PTEN-deficient PDGF-driven murine glioblastoma.
Volume: 6
Issue: 1
Pages: e14545
•
•
•
•
•
Publication
33020472 | J:298638
First Author: De Boeck A
Year: 2020
Journal: Nat Commun
Title: Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression.
Volume: 11
Issue: 1
Pages: 4997
•
•
•
•
•
Publication
32639068 | J:297579
First Author: Chen Z
Year: 2020
Journal: Glia
Title: Genetic driver mutations introduced in identical cell-of-origin in murine glioblastoma reveal distinct immune landscapes but similar response to checkpoint blockade.
Volume: 68
Issue: 10
Pages: 2148-2166
•
•
•
•
•
Publication
33300045 | J:354474
First Author: Ross JL
Year: 2021
Journal: Brain
Title: Platelet-derived growth factor beta is a potent inflammatory driver in paediatric high-grade glioma.
Volume: 144
Issue: 1
Pages: 53-69
•
•
•
•
•
Publication
28836293 | J:252858
First Author: Herting CJ
Year: 2017
Journal: Glia
Title: Genetic driver mutations define the expression signature and microenvironmental composition of high-grade gliomas.
Volume: 65
Issue: 12
Pages: 1914-1926
•
•
•
•
•
Publication
27199435 | J:231882
First Author: Quail DF
Year: 2016
Journal: Science
Title: The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas.
Volume: 352
Issue: 6288
Pages: aad3018
•
•
•
•
•
Publication
38416830 | J:345596
First Author: Yang F
Year: 2024
Journal: Sci Adv
Title: An immunosuppressive vascular niche drives macrophage polarization and immunotherapy resistance in glioblastoma.
Volume: 10
Issue: 9
Pages: eadj4678
•
•
•
•
•
Publication
37733448 | J:342600
 
First Author: Chen Z
Year: 2023
Journal: J Clin Invest
Title: A paracrine circuit of IL-1β/IL-1R1 between myeloid and tumor cells drives genotype-dependent glioblastoma progression.
Volume: 133
Issue: 22
•
•
•
•
•
Publication
28235764 | J:242079
First Author: Chen Z
Year: 2017
Journal: Cancer Res
Title: Cellular and Molecular Identity of Tumor-Associated Macrophages in Glioblastoma.
Volume: 77
Issue: 9
Pages: 2266-2278
•
•
•
•
•
Publication
31825829 | J:301999
First Author: Buonfiglioli A
Year: 2019
Journal: Cell Rep
Title: let-7 MicroRNAs Regulate Microglial Function and Suppress Glioma Growth through Toll-Like Receptor 7.
Volume: 29
Issue: 11
Pages: 3460-3471.e7
•
•
•
•
•
Publication
25829425 | J:225619
First Author: Nowak DG
Year: 2015
Journal: Cancer Discov
Title: MYC Drives Pten/Trp53-Deficient Proliferation and Metastasis due to IL6 Secretion and AKT Suppression via PHLPP2.
Volume: 5
Issue: 6
Pages: 636-51
•
•
•
•
•
Publication
34099734 | J:307910
First Author: Brady NJ
Year: 2021
Journal: Nat Commun
Title: Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer.
Volume: 12
Issue: 1
Pages: 3372
•
•
•
•
•
Publication
27341128 | J:240369
First Author: Das SK
Year: 2016
Journal: Oncotarget
Title: Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis.
Volume: 7
Issue: 30
Pages: 46848-46861
•
•
•
•
•
Publication
37567175 | J:339309
First Author: Chessa TAM
Year: 2023
Journal: Mol Cell
Title: PLEKHS1 drives PI3Ks and remodels pathway homeostasis in PTEN-null prostate.
Volume: 83
Issue: 16
Pages: 2991-3009.e13
•
•
•
•
•
Publication
25164012 | J:216695
First Author: Palmer CJ
Year: 2014
Journal: Cancer Res
Title: Zfx facilitates tumorigenesis caused by activation of the Hedgehog pathway.
Volume: 74
Issue: 20
Pages: 5914-24
•
•
•
•
•
Publication
32868382 | J:298565
First Author: Li G
Year: 2020
Journal: Cancer Res
Title: KDM5B Is Essential for the Hyperactivation of PI3K/AKT Signaling in Prostate Tumorigenesis.
Volume: 80
Issue: 21
Pages: 4633-4643
•
•
•
•
•
Publication
27536883 | J:243736
First Author: Gao D
Year: 2016
Journal: PLoS One
Title: A Tmprss2-CreERT2 Knock-In Mouse Model for Cancer Genetic Studies on Prostate and Colon.
Volume: 11
Issue: 8
Pages: e0161084
•
•
•
•
•
Publication
19878864 | J:153950
First Author: Morris JP 4th
Year: 2009
Journal: Cancer Cell
Title: It's a free for all--insulin-positive cells join the group of potential progenitors for pancreatic ductal adenocarcinoma.
Volume: 16
Issue: 5
Pages: 359-61
•
•
•
•
•
Publication
22624710 | J:189302
First Author: Barbacid M
Year: 2012
Journal: Cancer Cell
Title: Opening a new GATAway for treating KRAS-driven lung tumors.
Volume: 21
Issue: 5
Pages: 598-600
•
•
•
•
•
Publication
22975369 | J:192909
First Author: Perera RM
Year: 2012
Journal: Cancer Cell
Title: Ready, set, go: the EGF receptor at the pancreatic cancer starting line.
Volume: 22
Issue: 3
Pages: 281-2
•
•
•
•
•
Publication
24823632 | J:210594
First Author: Vonderheide RH
Year: 2014
Journal: Cancer Cell
Title: Tumor-promoting inflammatory networks in pancreatic neoplasia: another reason to loathe Kras.
Volume: 25
Issue: 5
Pages: 553-4
•
•
•
•
•
Publication
17297472 | J:122904
First Author: Luo F
Year: 2007
Journal: Oncogene
Title: Conditional expression of mutated K-ras accelerates intestinal tumorigenesis in Msh2-deficient mice.
Volume: 26
Issue: 30
Pages: 4415-27
•
•
•
•
•
Publication
30905671 | J:275676
First Author: Sullivan MR
Year: 2019
Journal: Cell Metab
Title: Increased Serine Synthesis Provides an Advantage for Tumors Arising in Tissues Where Serine Levels Are Limiting.
Volume: 29
Issue: 6
Pages: 1410-1421.e4
•
•
•
•
•
Publication
19412424 | J:265595
First Author: Hambardzumyan D
Year: 2009
Journal: Transl Oncol
Title: Modeling Adult Gliomas Using RCAS/t-va Technology.
Volume: 2
Issue: 2
Pages: 89-95
•
•
•
•
•
Publication
29949764 | J:271084
First Author: Ozawa T
Year: 2018
Journal: Cell Rep
Title: A De Novo Mouse Model of C11orf95-RELA Fusion-Driven Ependymoma Identifies Driver Functions in Addition to NF-κB.
Volume: 23
Issue: 13
Pages: 3787-3797
•
•
•
•
•
Publication
15967113 | J:100163
First Author: Hu X
Year: 2005
Journal: Neoplasia
Title: mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma.
Volume: 7
Issue: 4
Pages: 356-68
•
•
•
•
•
Publication
25117714 | J:214594
First Author: Ozawa T
Year: 2014
Journal: Cancer Cell
Title: Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma.
Volume: 26
Issue: 2
Pages: 288-300
•
•
•
•
•
Publication
28658205 | J:252222
First Author: Zabala-Letona A
Year: 2017
Journal: Nature
Title: mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer.
Volume: 547
Issue: 7661
Pages: 109-113
•
•
•
•
•
Publication
29057879 | J:250117
First Author: Hieronymus H
Year: 2017
Journal: Nat Commun
Title: Deletion of 3p13-14 locus spanning FOXP1 to SHQ1 cooperates with PTEN loss in prostate oncogenesis.
Volume: 8
Issue: 1
Pages: 1081
•
•
•
•
•
Publication
26037915 | J:225604
First Author: Resnick-Silverman L
Year: 2015
Journal: Cancer Discov
Title: Two Faces of SIVA.
Volume: 5
Issue: 6
Pages: 581-3
•
•
•
•
•
Publication
35982178 | J:330821
First Author: Yuan M
Year: 2022
Journal: Nat Cancer
Title: Cancer-associated fibroblasts employ NUFIP1-dependent autophagy to secrete nucleosides and support pancreatic tumor growth.
Volume: 3
Issue: 8
Pages: 945-960
•
•
•
•
•
Publication
27748748 | J:240751
First Author: International Cancer Genome Consortium PedBrain Tumor Project.
Year: 2016
Journal: Nat Med
Title: Recurrent MET fusion genes represent a drug target in pediatric glioblastoma.
Volume: 22
Issue: 11
Pages: 1314-1320
•
•
•
•
•
Publication
28394259 | J:244425
First Author: Huang Y
Year: 2017
Journal: J Clin Invest
Title: A proangiogenic signaling axis in myeloid cells promotes malignant progression of glioma.
Volume: 127
Issue: 5
Pages: 1826-1838
•
•
•
•
•
Publication
27935821 | J:293441
First Author: Yang Z
Year: 2017
Journal: Dis Model Mech
Title: Stromal hedgehog signaling maintains smooth muscle and hampers micro-invasive prostate cancer.
Volume: 10
Issue: 1
Pages: 39-52
•
•
•
•
•
Publication
20826752 | J:164283
First Author: Rolf J
Year: 2010
Journal: J Immunol
Title: Phosphoinositide 3-kinase activity in T cells regulates the magnitude of the germinal center reaction.
Volume: 185
Issue: 7
Pages: 4042-52
•
•
•
•
•
Publication
28875501 | J:256597
First Author: Yang CS
Year: 2017
Journal: Prostate
Title: The protein kinase C super-family member PKN is regulated by mTOR and influences differentiation during prostate cancer progression.
Volume: 77
Issue: 15
Pages: 1452-1467
•
•
•
•
•
Publication
28262675 | J:244308
 
First Author: Lefebure M
Year: 2017
Journal: Nat Commun
Title: Genomic characterisation of Eμ-Myc mouse lymphomas identifies Bcor as a Myc co-operative tumour-suppressor gene.
Volume: 8
Pages: 14581
•
•
•
•
•
Publication
20814421 | J:164580
First Author: Morris JP 4th
Year: 2010
Journal: Nat Rev Cancer
Title: KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma.
Volume: 10
Issue: 10
Pages: 683-95
•
•
•
•
•
Publication
23658296 | J:200542
First Author: Chen R
Year: 2013
Journal: Cancer Discov
Title: Two is better than one: combining IGF1R and MEK blockade as a promising novel treatment strategy against KRAS-mutant lung cancer.
Volume: 3
Issue: 5
Pages: 491-3
•
•
•
•
•
Publication
32289276 | J:287286
First Author: Drosten M
Year: 2020
Journal: Cancer Cell
Title: Targeting the MAPK Pathway in KRAS-Driven Tumors.
Volume: 37
Issue: 4
Pages: 543-550
•
•
•
•
•
Publication
30686754 | J:294965
 
First Author: Lee JS
Year: 2019
Journal: EBioMedicine
Title: Loss of SLC25A11 causes suppression of NSCLC and melanoma tumor formation.
Volume: 40
Pages: 184-197
•
•
•
•
•
Publication
4687397 | J:327631
First Author: Sluse FE
Year: 1973
Journal: Eur J Biochem
Title: Mechanism of the exchanges catalysed by the oxoglutarate translocator of rat-heart mitochondria. Kinetics of the external-product inhibition.
Volume: 32
Issue: 2
Pages: 283-91
•
•
•
•
•
Publication
35507647 | J:327478
First Author: Yuan Y
Year: 2022
Journal: Sci Adv
Title: α-Ketoglutaric acid ameliorates hyperglycemia in diabetes by inhibiting hepatic gluconeogenesis via serpina1e signaling.
Volume: 8
Issue: 18
Pages: eabn2879
•
•
•
•
•
Publication
29445180 | J:257943
First Author: Marazioti A
Year: 2018
Journal: Nat Commun
Title: Myeloid-derived interleukin-1β drives oncogenic KRAS-NF-κΒ addiction in malignant pleural effusion.
Volume: 9
Issue: 1
Pages: 672
•
•
•
•
•
Publication
18344980 | J:133950
First Author: Lim KH
Year: 2008
Journal: Nature
Title: Tumour maintenance is mediated by eNOS.
Volume: 452
Issue: 7187
Pages: 646-9
•
•
•
•
•
Publication
23358651 | J:198243
First Author: Konstantinidou G
Year: 2013
Journal: Cancer Discov
Title: RHOA-FAK is a required signaling axis for the maintenance of KRAS-driven lung adenocarcinomas.
Volume: 3
Issue: 4
Pages: 444-57
•
•
•
•
•
Publication
28249168 | J:256196
First Author: Rajbhandari N
Year: 2017
Journal: Cell Rep
Title: Autocrine IGF1 Signaling Mediates Pancreatic Tumor Cell Dormancy in the Absence of Oncogenic Drivers.
Volume: 18
Issue: 9
Pages: 2243-2255
•
•
•
•
•
Publication
37172086 | J:335643
First Author: Bu W
Year: 2023
Journal: Sci Adv
Title: Efficient cancer modeling through CRISPR-Cas9/HDR-based somatic precision gene editing in mice.
Volume: 9
Issue: 19
Pages: eade0059
•
•
•
•
•
Publication
30452622 | J:277563
First Author: Ni H
Year: 2019
Journal: Carcinogenesis
Title: ErbB4 acts as a suppressor in colitis and its associated carcinoma by negatively regulating cholesterol metabolism.
Volume: 40
Issue: 5
Pages: 680-686
•
•
•
•
•
Publication
37169967 | J:335562
     
First Author: Ely ZA
Year: 2023
Journal: Nat Biotechnol
Title: A prime editor mouse to model a broad spectrum of somatic mutations in vivo.
•
•
•
•
•
Publication
34193976 | J:317339
First Author: Thomas KR
Year: 2022
Journal: Leukemia
Title: Activated interleukin-7 receptor signaling drives B-cell acute lymphoblastic leukemia in mice.
Volume: 36
Issue: 1
Pages: 42-57
•
•
•
•
•
Publication
27270400 | J:244991
First Author: Akula MK
Year: 2016
Journal: Nat Immunol
Title: Control of the innate immune response by the mevalonate pathway.
Volume: 17
Issue: 8
Pages: 922-9
•
•
•
•
•
Publication
31140976 | J:277408
   
First Author: Spella M
Year: 2019
Journal: Elife
Title: Club cells form lung adenocarcinomas and maintain the alveoli of adult mice.
Volume: 8
•
•
•
•
•
Publication
27292643 | J:238300
First Author: Rowald K
Year: 2016
Journal: Cell Rep
Title: Negative Selection and Chromosome Instability Induced by Mad2 Overexpression Delay Breast Cancer but Facilitate Oncogene-Independent Outgrowth.
Volume: 15
Issue: 12
Pages: 2679-91
•
•
•
•
•
Publication
26657862 | J:230034
First Author: Edmonds MD
Year: 2016
Journal: J Clin Invest
Title: MicroRNA-31 initiates lung tumorigenesis and promotes mutant KRAS-driven lung cancer.
Volume: 126
Issue: 1
Pages: 349-64
•
•
•
•
•
Publication
20173739 | J:158125
First Author: Sotillo R
Year: 2010
Journal: Nature
Title: Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawal.
Volume: 464
Issue: 7287
Pages: 436-40
•
•
•
•
•
Publication
28980940 | J:258217
   
First Author: Zhang Y
Year: 2017
Journal: Elife
Title: Epithelial-Myeloid cell crosstalk regulates acinar cell plasticity and pancreatic remodeling in mice.
Volume: 6
•
•
•
•
•
Publication
23825589 | J:203456
First Author: González-Sánchez E
Year: 2013
Journal: PLoS One
Title: Lkb1 loss promotes tumor progression of BRAF(V600E)-induced lung adenomas.
Volume: 8
Issue: 6
Pages: e66933
•
•
•
•
•
Publication
16166301 | J:101615
First Author: Holmen SL
Year: 2005
Journal: Cancer Res
Title: Essential role for Ras signaling in glioblastoma maintenance.
Volume: 65
Issue: 18
Pages: 8250-5
•
•
•
•
•
Publication
20444198 | J:229152
First Author: VanBrocklin MW
Year: 2010
Journal: Pigment Cell Melanoma Res
Title: Targeted delivery of NRASQ61R and Cre-recombinase to post-natal melanocytes induces melanoma in Ink4a/Arflox/lox mice.
Volume: 23
Issue: 4
Pages: 531-41
•
•
•
•
•
Publication
36641749 | J:332854
First Author: Kim YE
Year: 2023
Journal: Cell Rep
Title: Reversibility and developmental neuropathology of linear nevus sebaceous syndrome caused by dysregulation of the RAS pathway.
Volume: 42
Issue: 1
Pages: 112003
•
•
•
•
•
Publication
34652874 | J:330726
First Author: Morishita M
Year: 2021
Journal: Genes Cells
Title: Characterization of mouse embryonic fibroblasts derived from Rassf6 knockout mice shows the implication of Rassf6 in the regulation of NF-κB signaling.
Volume: 26
Issue: 12
Pages: 999-1013
•
•
•
•
•
Publication
22144181 | J:181746
First Author: Xu J
Year: 2012
Journal: Blood
Title: Inhibiting the palmitoylation/depalmitoylation cycle selectively reduces the growth of hematopoietic cells expressing oncogenic Nras.
Volume: 119
Issue: 4
Pages: 1032-5
•
•
•
•
•
Publication
23512660 | J:195287
First Author: Wong CE
Year: 2013
Journal: Genes Dev
Title: Inflammation and Hras signaling control epithelial-mesenchymal transition during skin tumor progression.
Volume: 27
Issue: 6
Pages: 670-82
•
•
•
•
•
Publication
25593307 | J:218233
First Author: Wang L
Year: 2015
Journal: Genes Dev
Title: ATDC induces an invasive switch in KRAS-induced pancreatic tumorigenesis.
Volume: 29
Issue: 2
Pages: 171-83
•
•
•
•
•
Publication
26132860 | J:225835
 
First Author: Cha DJ
Year: 2015
Journal: Elife
Title: KRAS-dependent sorting of miRNA to exosomes.
Volume: 4
Pages: e07197
•
•
•
•
•
Publication
26725115 | J:231169
First Author: Erami Z
Year: 2016
Journal: Cell Rep
Title: Intravital FRAP Imaging using an E-cadherin-GFP Mouse Reveals Disease- and Drug-Dependent Dynamic Regulation of Cell-Cell Junctions in Live Tissue.
Volume: 14
Issue: 1
Pages: 152-167
•
•
•
•
•
Publication
39627248 | J:359313
First Author: Bastea LI
Year: 2024
Journal: Nat Commun
Title: Coxsackievirus and adenovirus receptor expression facilitates enteroviral infections to drive the development of pancreatic cancer.
Volume: 15
Issue: 1
Pages: 10547
•
•
•
•
•
Publication
29720585 | J:262915
First Author: Hyrenius-Wittsten A
Year: 2018
Journal: Nat Commun
Title: De novo activating mutations drive clonal evolution and enhance clonal fitness in KMT2A-rearranged leukemia.
Volume: 9
Issue: 1
Pages: 1770
•
•
•
•
•
Publication
30420765 | J:267434
First Author: Li S
Year: 2018
Journal: Nat Rev Cancer
Title: A model for RAS mutation patterns in cancers: finding the sweet spot.
Volume: 18
Issue: 12
Pages: 767-777
•
•
•
•
•
Publication
29941929 | J:268740
First Author: Patra KC
Year: 2018
Journal: Nat Cell Biol
Title: Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism.
Volume: 20
Issue: 7
Pages: 811-822
•
•
•
•
•
Publication
31134896 | J:277228
   
First Author: Adams CR
Year: 2019
Journal: Elife
Title: Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer.
Volume: 8
•
•
•
•
•
Publication
31041783 | J:289646
First Author: Hishida T
Year: 2019
Journal: Protein Cell
Title: Mutations in foregut SOX2+ cells induce efficient proliferation via CXCR2 pathway.
Volume: 10
Issue: 7
Pages: 485-495
•
•
•
•
•
Publication
32559497 | J:296299
First Author: Escobar-Hoyos LF
Year: 2020
Journal: Cancer Cell
Title: Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer.
Volume: 38
Issue: 2
Pages: 198-211.e8
•
•
•
•
•
Publication
33397922 | J:300957
First Author: Pickering KA
Year: 2021
Journal: Nat Commun
Title: A RAC-GEF network critical for early intestinal tumourigenesis.
Volume: 12
Issue: 1
Pages: 56
•
•
•
•
•
Publication
33610731 | J:303946
 
First Author: Munagala R
Year: 2021
Journal: Cancer Lett
Title: Exosome-mediated delivery of RNA and DNA for gene therapy.
Volume: 505
Pages: 58-72
•
•
•
•
•
Publication
33589425 | J:307163
     
First Author: Pitarresi JR
Year: 2021
Journal: Cancer Discov
Title: PTHrP drives pancreatic cancer growth and metastasis and reveals a new therapeutic vulnerability.
•
•
•
•
•
Publication
29340023 | J:309222
First Author: Mao Y
Year: 2017
Journal: Oncotarget
Title: Role and regulation of Yap in KrasG12D-induced lung cancer.
Volume: 8
Issue: 67
Pages: 110877-110889
•
•
•
•
•
Publication
34380736 | J:309468
 
First Author: Castel P
Year: 2021
Journal: Proc Natl Acad Sci U S A
Title: RAS interaction with Sin1 is dispensable for mTORC2 assembly and activity.
Volume: 118
Issue: 33
•
•
•
•
•
Publication
32589309 | J:326402
First Author: Zhong C
Year: 2020
Journal: Cancer Sci
Title: ZNF251 promotes the progression of lung cancer by activating ERK signaling.
Volume: 111
Issue: 9
Pages: 3236-3244
•
•
•
•
•
Publication
24982195 | J:320715
First Author: Sinkevicius KW
Year: 2014
Journal: Proc Natl Acad Sci U S A
Title: Neurotrophin receptor TrkB promotes lung adenocarcinoma metastasis.
Volume: 111
Issue: 28
Pages: 10299-304
•
•
•
•
•
Publication
35139374 | J:327104
First Author: Venkatanarayan A
Year: 2022
Journal: Cell Rep
Title: CRAF dimerization with ARAF regulates KRAS-driven tumor growth.
Volume: 38
Issue: 6
Pages: 110351
•
•
•
•
•
Publication
35562376 | J:324554
First Author: Liu Y
Year: 2022
Journal: Nat Commun
Title: Rapid acceleration of KRAS-mutant pancreatic carcinogenesis via remodeling of tumor immune microenvironment by PPARδ.
Volume: 13
Issue: 1
Pages: 2665
•
•
•
•
•
Publication
35589755 | J:324987
First Author: Hall AE
Year: 2022
Journal: Nat Commun
Title: RNA splicing is a key mediator of tumour cell plasticity and a therapeutic vulnerability in colorectal cancer.
Volume: 13
Issue: 1
Pages: 2791
•
•
•
•
•
Publication
35262628 | J:329458
 
First Author: Jiang H
Year: 2022
Journal: J Exp Med
Title: Ferrous iron-activatable drug conjugate achieves potent MAPK blockade in KRAS-driven tumors.
Volume: 219
Issue: 4
•
•
•
•
•
Publication
36810256 | J:333757
 
First Author: Xie Y
Year: 2023
Journal: JCI Insight
Title: SETD2 regulates chromatin accessibility and transcription to suppress lung tumorigenesis.
Volume: 8
Issue: 4
•
•
•
•
•
Publication
37845485 | J:344824
First Author: Feng Z
Year: 2024
Journal: Nat Cancer
Title: An in vitro-transcribed circular RNA targets the mitochondrial inner membrane cardiolipin to ablate EIF4G2(+)/PTBP1(+) pan-adenocarcinoma.
Volume: 5
Issue: 1
Pages: 30-46
•
•
•
•
•
Publication
38605037 | J:347359
First Author: Fu J
Year: 2024
Journal: Nat Commun
Title: Nardilysin-regulated scission mechanism activates polo-like kinase 3 to suppress the development of pancreatic cancer.
Volume: 15
Issue: 1
Pages: 3149
•
•
•
•
•
Publication
18178811 | J:130950
First Author: Janas ML
Year: 2008
Journal: J Immunol
Title: The effect of deleting p110delta on the phenotype and function of PTEN-deficient B cells.
Volume: 180
Issue: 2
Pages: 739-46
•
•
•
•
•
Publication
26809587 | J:230653
 
First Author: Grego-Bessa J
Year: 2016
Journal: Elife
Title: The tumor suppressor PTEN and the PDK1 kinase regulate formation of the columnar neural epithelium.
Volume: 5
Pages: e12034
•
•
•
•
•
Publication
19076778 | J:173443
First Author: Huse JT
Year: 2009
Journal: Brain Pathol
Title: Genetically engineered mouse models of brain cancer and the promise of preclinical testing.
Volume: 19
Issue: 1
Pages: 132-43
•
•
•
•
•
Publication
30484104 | J:307676
First Author: Hollern DP
Year: 2019
Journal: Breast Cancer Res Treat
Title: A mouse model featuring tissue-specific deletion of p53 and Brca1 gives rise to mammary tumors with genomic and transcriptomic similarities to human basal-like breast cancer.
Volume: 174
Issue: 1
Pages: 143-155
•
•
•
•
•
Publication
34521767 | J:311175
 
First Author: Andrijes R
Year: 2021
Journal: Proc Natl Acad Sci U S A
Title: Tetraspanin 6 is a regulator of carcinogenesis in colorectal cancer.
Volume: 118
Issue: 39
•
•
•
•
•
Publication
32567731 | J:301694
First Author: Raposo TP
Year: 2020
Journal: Int J Exp Pathol
Title: Tensin4 (TNS4) is upregulated by Wnt signalling in adenomas in multiple intestinal neoplasia (Min) mice.
Volume: 101
Issue: 3-4
Pages: 80-86
•
•
•
•
•
Publication
31237864 | J:297143
   
First Author: Gbenedio OM
Year: 2019
Journal: JCI Insight
Title: RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancer.
Volume: 5
•
•
•
•
•
Publication
19690388 | J:152703
First Author: Lee D
Year: 2009
Journal: J Clin Invest
Title: Tumor-specific apoptosis caused by deletion of the ERBB3 pseudo-kinase in mouse intestinal epithelium.
Volume: 119
Issue: 9
Pages: 2702-13
•
•
•
•
•
Publication
16397217 | J:105038
First Author: Reilly KM
Year: 2006
Journal: Cancer Res
Title: An imprinted locus epistatically influences Nstr1 and Nstr2 to control resistance to nerve sheath tumors in a neurofibromatosis type 1 mouse model.
Volume: 66
Issue: 1
Pages: 62-8
•
•
•
•
•
Publication
18472967 | J:138670
First Author: Lyustikman Y
Year: 2008
Journal: Neoplasia
Title: Constitutive activation of Raf-1 induces glioma formation in mice.
Volume: 10
Issue: 5
Pages: 501-10
•
•
•
•
•
Publication
17575131 | J:122413
First Author: Yang G
Year: 2007
Journal: Cancer Res
Title: Loss of xeroderma pigmentosum C (Xpc) enhances melanoma photocarcinogenesis in Ink4a-Arf-deficient mice.
Volume: 67
Issue: 12
Pages: 5649-57
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom